Touch-me-not

Adenanthera pavonina seeds and leaves contain bioactive compounds including saponins, flavonoids, triterpenoids, trypsin inhibitor proteins, O-acetylethanolamine, and volatile terpenoids such as sabinene (27.9%) and D-limonene (14.79%), with molecular docking studies identifying diazoprogesterone as a candidate inhibitor of mutated insulin receptor tyrosine kinase (docking score −9.2 kcal/mol). Preclinical evidence in streptozotocin-induced diabetic rats suggests that aqueous seed extracts can reduce blood glucose, HbA1c, lipid levels, and markers of renal injury over 13 weeks, though no human clinical trials have been conducted to confirm these effects.

Origin & History

Adenanthera pavonina is pantropically native to tropical Asia, including India, Sri Lanka, Malaysia, and across the Pacific Islands, and has naturalized widely throughout the Caribbean, Africa, and Oceania including Samoa. It thrives in lowland tropical forests, disturbed habitats, and coastal margins, tolerating a range of soil types and high humidity. The tree is cultivated ornamentally for its vivid scarlet seeds and has long been integrated into agroforestry systems across Pacific Island communities.

Historical & Cultural Context

Adenanthera pavonina has been employed across South and Southeast Asian, Pacific Island, and Caribbean traditional medicine systems for a remarkably diverse range of conditions, including diarrhea, stomach hemorrhage, hematuria, boils, inflammation, blood disorders, arthritis, rheumatism, cholera, paralysis, epilepsy, convulsions, spasms, indigestion, hypertension, gout, and cancer. In Samoa, the seeds hold particular significance as a traditional remedy for fever, and the bright red seeds have also been used as currency and jewelry beads across South and Southeast Asia, earning the tree the name 'coral bead tree' or 'red bead tree' in many regions. The species appears in Ayurvedic and Unani texts as a treatment for skin diseases and rheumatic disorders, with ground seeds applied as poultices and decoctions prepared from bark and leaves administered internally. The tree's pantropical spread facilitated the transfer of its medicinal applications across diverse ethnobotanical traditions, making it one of the more widely documented multi-indication plants of the humid tropics.

Health Benefits

- **Antidiabetic Potential**: Aqueous seed extracts reduced blood glucose and HbA1c in STZ-induced diabetic rat models over 13 weeks, with molecular docking identifying diazoprogesterone as an inhibitor of mutated insulin receptor tyrosine kinase at −9.2 kcal/mol, suggesting a mechanistic basis for glycemic modulation.
- **Anti-inflammatory Activity**: O-acetylethanolamine isolated from seed and pod extracts exerts anti-inflammatory effects, and kernel extracts have demonstrated inhibition of inflammatory mediators in preclinical assays, supporting traditional use for arthritis and rheumatism.
- **Antinociceptive Effects**: Bark extracts produce analgesic effects in rodent models via opioid receptor pathways (naloxone-reversible), with additional involvement of the cGMP signaling pathway as evidenced by potentiation with methylene blue, indicating a dual-mechanism pain-modulating action.
- **Renal Protective Properties**: In diabetic rat studies, aqueous seed extract treatment reduced proteinuria, albuminuria, serum creatinine, and urea levels compared to diabetic controls, suggesting nephroprotective activity possibly mediated by improved glycemic control and anti-inflammatory compounds.
- **Lipid-Lowering Effects**: The same 13-week preclinical trial in diabetic rats demonstrated reductions in serum lipid levels with aqueous seed extract treatment, consistent with the presence of saponins and sterols including β-sitosterol glucoside and stigmasterol glucoside identified in seeds and leaves.
- **Antioxidant and Phytochemical Activity**: Leaves contain polyphenols, flavonoids, tannins, coumarins, and galactomannans with established free-radical scavenging potential in vitro, with GC-MS-identified sesquiterpenes such as 2-Naphthalenemethanol decahydro derivatives contributing to this antioxidant profile.
- **Traditional Antipyretic Use in Samoa**: Seeds have been used in Samoan traditional medicine specifically for the management of fever, aligning with the known anti-inflammatory and possibly prostaglandin-modulating activity of flavonoids and triterpenoids present in seed preparations.

How It Works

Molecular docking and 100-nanosecond molecular dynamics simulations demonstrate that diazoprogesterone, identified by GC-MS in methanolic leaf extracts, binds stably to the mutated insulin receptor tyrosine kinase (PDB: 5hhw) with a docking score of −9.2 kcal/mol, potentially inhibiting aberrant glucose uptake pathways implicated in type 2 diabetes mellitus. O-acetylethanolamine from seed and pod extracts provides anti-inflammatory activity, likely through modulation of eicosanoid biosynthesis or endocannabinoid-adjacent pathways. Bark-derived antinociceptive compounds engage opioid receptors, as confirmed by naloxone reversibility in rodent models, with the cGMP pathway serving as a secondary signaling axis since methylene blue (a guanylate cyclase inhibitor) enhances rather than blocks the analgesic response. Trypsin inhibitor proteins of 17 kDa and 15 kDa in seeds inhibit serine protease activity, which may contribute to anti-inflammatory and potentially antinutritional effects depending on dose and preparation method.

Scientific Research

The available evidence for Adenanthera pavonina is exclusively preclinical, comprising in vitro phytochemical characterization, in silico molecular docking and molecular dynamics studies, and in vivo rodent experiments, with no published human clinical trials identified in the literature. A key in vivo study employed STZ-induced diabetic rats treated with aqueous seed extract (APSAE) over 13 weeks, measuring outcomes including blood glucose, HbA1c, lipid profile, renal biomarkers, and body weight, but the study did not report sample sizes, confidence intervals, or effect sizes, substantially limiting interpretability. GC-MS characterization of methanolic leaf extracts identified 17 phytochemicals with favorable ADMET profiles for select compounds, and in silico docking studies provide mechanistic hypotheses, but these computational findings require validation in biological systems. The current evidence base is characteristic of an early-stage ethnobotanical research program, and all findings must be considered hypothesis-generating rather than clinically actionable.

Clinical Summary

No human clinical trials have been conducted on Adenanthera pavonina in any preparation or indication. The most substantive in vivo data come from a 13-week study in streptozotocin-induced diabetic rats using aqueous seed extract, which reported reductions in blood glucose, HbA1c, proteinuria, albuminuria, serum lipids, creatinine, and urea relative to untreated diabetic controls, with body weight increases exceeding those in the glibenclamide group. However, the absence of reported sample sizes, statistical parameters, and effect sizes in available data significantly limits the quality assessment of this study. Confidence in translating these preclinical results to human therapeutic applications is low, and rigorous Phase I/II clinical trials with standardized preparations are needed before any clinical recommendations can be made.

Nutritional Profile

Adenanthera pavonina seeds are proteinaceous legume seeds containing trypsin inhibitor proteins at 17 kDa and 15 kDa molecular weights, which reduce net protein digestibility and represent an antinutritional factor in raw seed consumption. Seeds and pods contain saponins, steroids including β-sitosterol glucoside and stigmasterol glucoside, glycosides, and polysaccharides including galactomannans, which contribute dietary fiber equivalents. Leaves contain octacosanol (a long-chain fatty alcohol), dulcitol (a sugar alcohol), flavonoids, polyphenols, tannins, and coumarins, with the volatile fraction dominated by sabinene (27.9%) and D-limonene (14.79%) in leaf essential oil. No quantified macronutrient or micronutrient data (protein percentage, fat content, mineral concentrations) are available from peer-reviewed sources for any plant part, and bioavailability of phytochemicals has not been assessed in humans.

Preparation & Dosage

- **Aqueous Seed Extract (APSAE)**: Used in preclinical diabetic rat studies over 13 weeks; no human-equivalent dose established; traditional preparation involves grinding dried seeds and preparing decoctions in water.
- **Methanolic Leaf Extract**: Used in in vitro and in silico research; not a recognized supplemental form; laboratory preparation involves maceration in methanol followed by filtration and concentration.
- **Ground Seeds (Traditional, Samoan)**: Seeds ground and administered orally for fever management; no standardized dose or preparation protocol documented in ethnobotanical literature.
- **Bark Decoction**: Used traditionally for pain relief and inflammatory conditions; preclinical antinociceptive studies used unspecified crude bark extracts; no dose-ranging data available.
- **Kernel Extract**: Applied traditionally and tested preclinically for anti-inflammatory effects; no standardized form or dosage established.
- **Supplemental Forms**: No commercially standardized capsules, tablets, or extracts are currently available; all uses remain at the level of traditional or experimental crude preparations.
- **Standardization**: No phytochemical standardization markers or minimum content specifications have been established for any preparation of Adenanthera pavonina.

Synergy & Pairings

No peer-reviewed synergy studies have been conducted for Adenanthera pavonina with other ingredients; however, the co-presence of β-sitosterol glucoside and saponins within the plant itself suggests potential additive lipid-lowering effects when combined with other phytosterol-containing preparations, as β-sitosterol is established to competitively inhibit intestinal cholesterol absorption. The anti-inflammatory activity of O-acetylethanolamine from seeds may theoretically complement the analgesic opioid-pathway activity of bark alkaloids in multi-extract preparations, though no combination studies exist. Given the proposed insulin receptor tyrosine kinase inhibition by diazoprogesterone, combining standardized seed or leaf extracts with established insulin sensitizers such as berberine represents a hypothesis-generating synergy stack warranting preclinical investigation.

Safety & Interactions

No human safety data, documented adverse effects, or established maximum safe doses exist for Adenanthera pavonina in any preparation; all preclinical studies describe crude extracts as 'relatively safe' compared to synthetic agents, but this characterization lacks rigorous toxicological validation. The presence of trypsin inhibitor proteins (17 kDa and 15 kDa) in raw seeds poses a meaningful antinutritional concern, as these compounds can impair protein digestion and potentially reduce absorption of dietary proteins when seeds are consumed without adequate heat processing. No specific drug interaction data are available, though the proposed anti-diabetic mechanism involving insulin receptor tyrosine kinase modulation raises a theoretical concern for additive hypoglycemic effects if combined with insulin secretagogues, biguanides, or insulin itself. Pregnancy and lactation safety has not been studied; traditional use in some regions for abortifacient or emmenagogue purposes has been reported anecdotally, and therefore use in pregnant or lactating individuals cannot be considered safe based on current evidence.